FDA lays out what to ex­pect at ad­com­m's se­lec­tion of strains for Covid-19 vac­cine cam­paign this fall

The FDA on Mon­day pub­lished its brief­ing doc­u­ments ahead of Thurs­day’s vac­cine ad­vi­so­ry com­mit­tee, with the ex­perts ready­ing a rec­om­men­da­tion on what Covid-19 strains to use for the up­com­ing vac­cine sea­son, as the agency typ­i­cal­ly does for every flu sea­son.

The meet­ing will be cru­cial for Mod­er­na, Pfiz­er and BioN­Tech, and No­vavax, all of which have ap­proved or au­tho­rized (as in the case of No­vavax) Covid-19 vac­cines that will be up­dat­ed this fall.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.